ITEMS

modern scholarly publishers in the finest tradition

Journals

	Search

Journal of Environmental Pathology, Toxicology and Oncology

ISSN for PRINT: 0731-8898

Institutional price:	$725.00
Issues per year:	4

Best Paper Award Selection - Editorial Board Site

2007, Volume26

98 pages

Issue price - $187.00

Fluorescence Monitoring of a Topically Applied Liposomal Temoporfin Formulation and Photodynamic Therapy of Nonpigmented Skin Malignancies

Niels Bendsoe
Department of Dermatology, Lund University Hospital, Lund University Medical Laser Centre, SE-221 00 Lund, Sweden; Department of Dermatology, Lund University Hospital, SE-221 85 Lund, Sweden

Linda Persson
Department of Physics, Lund University, Lund, Sweden

Ann Johansson
Department of Physics, Lund University, Lund, Sweden

Johan Axelsson
Department of Physics, Lund University, Lund, Sweden

Jenny Svensson
Department of Physics, Lund University, Lund, Sweden

Susanna Grafe
Research & Development, Biolitec AG, Jena, Germany

Tilmann Trebst
Research & Development, Biolitec AG, Jena, Germany

Stefan Andersson-Engels
Lund University Medical Laser Centre; Department of Physics, Lund Institute of Technology, SE-221 00 Lund, Sweden

Sune Svanberg
Lund University Medical Laser Centre; Department of Physics, Lund Institute of Technology, SE-221 00 Lund, Sweden

Katarina Svanberg
Lund University Medical Laser Centre; Department of Oncology, Lund University Hospital, SE-221 85 Lund, Sweden

ABSTRACT

Meso-tetra(hydroxyphenyl)chlorin (mTHPC) (INN: Temoporfin) is a potent photodynamically active substance in clinical use today. Usually, the substance is given systemically and a known drawback with this administration route is a prolonged skin light sensitization. For the first time to our knowledge, a liposomal Temoporfin gel formulation for topical application was studied in connection with photodynamic therapy (PDT) of nonpigmented skin malignancies in humans. Intervals of 4 hr between drug administration and light irradiation were used. Sensitizer distribution within tumor and surrounding normal skin was investigated by means of point monitoring and imaging fluorescence spectroscopy before, during, and after PDT, showing high tumor selectivity. Furthermore, the bleaching of Temoporfin was studied during the PDT procedure by monitoring the fluorescence following excitation by using a therapeutic light. A 30−35% light-induced photometabolization was shown. No pain occurred during or after treatment. It was also observed that the treated area did not show any swollen tissue or reddening, as is often seen in PDT using topical δ-aminolevulinic acid. On controlling the patients one week after treatment, healing progress was observed in several patients and no complications were registered.